Company news
Ispecimen Inc. (NASDAQ:ISPC) news
Ispecimen Inc. news releases on 6ix. Latest, Sep 29, 2026: iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Press releases & updates
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
September 28, 2026
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
August 7, 2026
ISpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
August 6, 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
May 12, 2026
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 7, 2026
ISpecimen Announces 1-for-40 Reverse Stock Split
April 27, 2026
iSpecimen Announces 1-for-40 Reverse Stock Split
April 24, 2026
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
April 9, 2026
ISpecimen Achieves Rapid Procurement Milestone for Influenza Research
March 16, 2026
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
March 12, 2026
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
February 6, 2026
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
February 6, 2026
Nuwellis Announces Changes to Board of Directors
January 23, 2026
E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.’s ~$5.5 Million Private Placement
January 6, 2026
iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement
December 30, 2025
iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform
August 21, 2025
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
August 4, 2025
iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market
July 31, 2025
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
July 28, 2025
Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
July 28, 2025
iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
July 25, 2025
iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
July 24, 2025
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
December 19, 2024
iSpecimen Appoints Robert Lim as CEO and Director
December 11, 2024
iSpecimen Reports Third Quarter 2024 Results
November 6, 2024
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
November 6, 2024
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
October 30, 2024
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
October 29, 2024
iSpecimen Announces 1-for-20 Reverse Stock Split
September 10, 2024
iSpecimen Reports Second Quarter 2024 Results
August 5, 2024
iSpecimen to Report Second Quarter 2024 Results on August 6, 2024
July 24, 2024
iSpecimen Reports First Quarter 2024 Results
May 6, 2024
iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024
April 24, 2024
iSpecimen Reports Full Year 2023 Results
March 13, 2024
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
March 11, 2024
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
January 22, 2024
iSpecimen Strengthens Global Oncology Biospecimen Offering
December 6, 2023
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
November 1, 2023
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
October 25, 2023
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
October 22, 2023
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
September 27, 2023
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
September 5, 2023
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
August 29, 2023
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
August 15, 2023
iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
August 8, 2023
iSpecimen Reports Second Quarter 2023 Financial and Operating Results
August 1, 2023
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023
July 24, 2023
Thirteen New Biospecimen Suppliers Added to iSpecimen’s Proprietary Provider Network
July 5, 2023
iSpecimen Reports First Quarter 2023 Results
May 3, 2023
iSpecimen to Report First Quarter 2023 Results on May 4, 2023
April 19, 2023